Navigation Links
Angiotech's corporate partner, Boston Scientific, announces launch of third-generation TAXUS(R) Element(TM) Stent
Date:5/19/2009

VANCOUVER, May 19 /PRNewswire-FirstCall/ - Angiotech Pharmaceuticals, Inc. (NASDAQ: ANPI, TSX: ANP) today announced that its corporate partner, Boston Scientific Corporation (NYSE: BSX) has launched the platinum chromium TAXUS(R) Element(TM) Paclitaxel-Eluting Coronary Stent System in select markets worldwide. The TAXUS Element Stent features a new platinum chromium alloy engineered specifically for coronary stent applications and represents the Company's third-generation drug-eluting stent (DES) technology.

The TAXUS Element Stent is built on the advanced platinum chromium platform and is designed to provide interventional cardiologists improved performance in treating patients with complex coronary artery disease. Boston Scientific has reported that it anticipates CE Mark approval for the TAXUS Element Stent in the fourth quarter of this year.

"Boston Scientific continues to make significant progress toward improving the performance of TAXUS stents," said Dr. William Hunter, President and CEO of Angiotech. "The launch of this third-generation TAXUS stent demonstrates the efficacy and longevity of the paclitaxel platform in treating patients with heart disease."

The platinum chromium alloy used in the Element Stent System was engineered specifically for coronary stenting, delivering both strength and flexibility. The Element Stent System platform also features a new stent architecture with thinner struts, increased flexibility and a lower profile, designed to improve radial strength, recoil and angiographic visibility. Deliverability to complex lesions is further enhanced through the incorporation of a new highly deliverable dilatation catheter technology.

"Our platinum chromium Element Stent series represents a significant leap forward in
'/>"/>

SOURCE Angiotech Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. DJO Incorporateds Pending Merger With ReAble Therapeutics Clears U.S. Antitrust Review
2. China Medical Technologies to Participate in the Morgan Stanleys 2007 China Medical Corporate Day
3. Vical Names Andrew de Guttadauro Vice President, Corporate Development
4. Signalife Provides Corporate Update
5. Biomira Announces Plan to Reincorporate in the United States
6. Pressure BioSciences, Inc. Provides Corporate Update
7. The 4th Annual BIO Investor Forum to Webcast Alexzas Corporate Presentation
8. Clinsys Clinical Research, Inc. Announces Relocation of Corporate Headquarters
9. ProMed Alliance International Inc. Corporate Name and Trading Symbol Expected to Change Effective Tomorrow
10. MultiCell Technologies Signs Worldwide Exclusive License Agreement With Corning Incorporated
11. New Corporate Website Launched - Focus on Life Scientists, Flow Cytometrists, & Clinicians
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/14/2014)... , July 14, 2014 Cloud ... drug design and development, announced today the expansion ... company has been granted supercomputing time at Argonne ... targets.  Through a discretionary allocation ... Computing Facility (ALCF), researchers at Cloud Pharmaceuticals will ...
(Date:7/14/2014)... July 14, 2014 Throughout this ... across the clinical trials space, representing 38 countries ... series entitled “Optimizing Patient Participation in Clinical Trials. ... off with internationally renowned R&D expert, Ken Getz, ... on Reinventing Drug Development through Patient Centricity. , ...
(Date:7/14/2014)... CAMBRIDGE, Mass. , July 14, 2014 ... in the development of new therapies to treat neuropsychiatric ... Ahlholm has been appointed vice president of finance ... Mr. Ahlholm is a senior executive with more ... functions at technology and life science companies. His background ...
(Date:7/14/2014)... (PRWEB) July 14, 2014 ... registry platform, announced that three PatientCrossroads-based patient ... the Phelan-McDermid Syndrome International Registry; and the ... been awarded contracts by the Patient-Centered Outcomes ... creation of a new health data network ...
Breaking Biology Technology:Cloud Pharmaceuticals Granted 1M Hours of Supercomputer Time to Target Orphan Diseases Including Malaria 2Optimizing Patient Participation in Clinical Trials: Attract. Engage. Retain. – eCongress eBox Archives Now Available 2Optimizing Patient Participation in Clinical Trials: Attract. Engage. Retain. – eCongress eBox Archives Now Available 3Optimizing Patient Participation in Clinical Trials: Attract. Engage. Retain. – eCongress eBox Archives Now Available 4Optimizing Patient Participation in Clinical Trials: Attract. Engage. Retain. – eCongress eBox Archives Now Available 5Minerva Neurosciences Announces Appointment Of Frederick W. Ahlholm As VP Of Finance And Chief Accounting Officer 2PatientCrossroads Fuels Development of New National Clinical Research Network 2PatientCrossroads Fuels Development of New National Clinical Research Network 3
... Md., Aug. 30 Micromet, Inc.,(Nasdaq: MITI ... of,novel, proprietary antibody-based products for cancer, inflammation and,autoimmune ... and,Chief Executive Officer of Micromet, will present at ... Germany on Wednesday,September 5, 2007 at 9:50am Eastern ...
... Aug. 29 Sucampo,Pharmaceuticals, Inc. (Nasdaq: SCMP ) ... have exercised in full their option to,purchase 562,500 shares ... that the closing of that purchase took place on ... closing were sold by a selling,stockholder and Sucampo did ...
... Mass., Aug. 29 Millennium,Pharmaceuticals, Inc. (Nasdaq: ... presentation,at the Thomas Weisel Partners 2007 Healthcare ... accessed by visiting the Investors section of ... http://www.newscom.com/cgi-bin/prnh/19991220/MLNMLOGO ) The presentation ...
Cached Biology Technology:Micromet, Inc. to Present at the Sal. Oppenheim 2nd European Healthcare Conference 2Sucampo Pharmaceuticals Announces Exercise and Closing of IPO Over-Allotment Option 2Thomas Weisel Partners 2007 Healthcare Conference To Webcast Millennium Presentation 2
(Date:7/14/2014)... the discovery and description of Rhipidocyrtus muiri - ... out to represent a new genus and species. The long ... Borneo is discussed in a recent paper published in the ... holotype male, and only known specimen of Rhipidocyrtus muiri ... to this it was transferred among several researchers in the ...
(Date:7/14/2014)... in the local environment manage much better in the ... environments. , A world without bees would be ... an additional 600 million to 1 billion Danish kroner ... bees making honey and pollinating a wide range of ... bees all over the world are under pressure from ...
(Date:7/14/2014)... Roquin protein, discovered in 2005, controls T-cell activation ... mRNAs. In doing so, it helps to guarantee ... body,s own structures that can lead to autoimmune ... diseases affect between five and ten per cent ... result of complex environmental influences when a genetic ...
Breaking Biology News(10 mins):Serendipity at the Smithsonian: The 107-year journey of the beetle Rhipidocyrtus muiri 2Serendipity at the Smithsonian: The 107-year journey of the beetle Rhipidocyrtus muiri 3Best for bees to be stay-at-homes 2Molecular mechanisms underlying the prevention of autoim-munity by Roquin revealed 2
... Boston University have taught bacteria how to count. Professor ... sequence of genes that allow the microbes to count ... potential applications, which could include drug delivery and sensing ... application still to be addressed within synthetic biology: Can ...
... Each year the American Institute of Biological ... outstanding contributions to the biological sciences. Since ... annually to individuals who have made significant scientific ... fields of integrative and organismal biology. The ...
... Ludwig Institute for Cancer Research at the University of ... remarkable property of the contractile ring, a structure required ... works to divide the cell may facilitate development of ... The researchers show that even though both ...
Cached Biology News:Boston University biomedical engineers teach bacteria to count 2Boston University biomedical engineers teach bacteria to count 3Two Central High (Philadelphia) grads honored by AIBS 2Study may aid efforts to prevent uncontrolled cell division in cancer 2
Protein Kinase D2 Immunogen: Human protein kinase D2. Storage: -20 C, Avoid Freeze/Thaw Cycles...
...
... Upright Freezer Inventory Storage Racks for ... available to fit all makes and ... Made of high quality stainless ... high fiberboard, stainless steel or plastic ...
Many mammalian cell types and experimental situations create challenges for standard transfection experiments. The ViraPower Lentiviral Expression System overcomes these challenges with efficient vir...
Biology Products: